A study to assess the even break of undertaking a UK-based genetic genetic screening trial for lung cancer has been commissioned by the national precedent for Health probing Health machinery valuation (NIHR HTA) programme. Lung cancer kills more people cosmopolitan than any other malignancy accounting for around 1.4 million deaths each year, and around 38,000 individuals are diagnosed with the disease in the UK each year.

More: - Brought to my attention by